Annapolis, MD--The fifth annual International Plasma Awareness Week (IPAW) will be celebrated October 8-14. A joint initiative of the Plasma Protein Therapeutics Association (PPTA) and its member companies, IPAW is designed to:

ANNAPOLIS, Md., Oct. 9, 2016 /PRNewswire/ -- The Plasma Protein Therapeutics Association (PPTA) and its member companies are sponsoring International Plasma Awareness Week, October 9-15 designed to:

The Plasma Protein Therapeutics Association (PPTA) Global Board of Directors elected Mr. David Ian Bell as the new Chairman, effective January 2016. Mr. Bell will serve as Chairman for a term of three years.

Annapolis, MD—The Plasma Protein Therapeutics Association (PPTA) and its member companies are sponsoring International Plasma Awareness Week, October 11-17 designed to:

Annapolis, Md.— On October 8, the Honorable Doris O. Matsui (D-CA) entered into the Congressional Record her statement recognizing the third annual International Plasma Awareness Week (IPAW), to be celebrated October 11-17.

September 16, 2015—The Plasma Protein Therapeutics Association (PPTA) and its member companies are sponsoring the third annual International Plasma Awareness Week, October 11-17.

PPTA would like to recognize Alabama for demonstrating the important role source plasma plays in saving and improving patients’ lives.

April 14, 2015–The Plasma Protein Therapeutics Association recognizes World Hemophilia Day, an annual international event sponsored by the World Federation for Hemophilia that seeks to raise awareness of people living with inherited bleeding disorders.

The Plasma Protein Therapeutics Association joins more than 300 organizations in 56 countries in recognizing the 8th annual International Rare Disease Day on February 28. 

Sponsored by the National Organization of Rare Disorders and Rare Diseases Europe, Rare Diseases Day seeks to raise awareness among the general public and policymakers about rare diseases, impacting lives all over the globe. 

(20th January 2015 – Brussels) – AESGP, EFPIA, EGA, and PPTA are pleased to announce today’s release of the joint principles for “Communication of information on quality and manufacturing potential supply disruption”. This document forms part of the  industry response to the EMA (European Medicines Agency) call for voluntary and proactive action, to provide European patients with continuous access to medicines.